George Tambassis, Pharmacist, ex-National Guild President, and chair of the Australian Biosimilar Academy Advisory Board outlines the importance of pharmacist involvement in understanding biosimilars. Given the government supported Community Pharmacy Agreement, he highlights how pharmacists are empowered with the capability to switch a patient from a biologic to a biosimilar. George’s focus is ensuring that,
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.